Q4 2024 Aster DM Healthcare Ltd Earnings Call Transcript
Key Points
- Aster DM Healthcare Ltd (BOM:540975) reported a significant growth in India operations with a 24% year-on-year revenue increase to INR3,699 crores.
- The company achieved a strong operating EBITDA growth of 30% year-on-year, reaching INR620 crores in FY24.
- Aster DM Healthcare Ltd (BOM:540975) successfully completed the GCC segregation, allowing for tailored strategies and positioning for growth in the Indian healthcare market.
- The company plans to add 1,700 beds within the next three years through Brownfield and Greenfield projects, enhancing capacity and service offerings.
- Aster DM Healthcare Ltd (BOM:540975) distributed approximately 80% of the proceeds from the GCC business sale as a special dividend, reflecting strong shareholder returns.
- The Andhra and Telangana clusters showed underperformance, with the company acknowledging the need for intervention and improvement.
- Despite the overall growth, the EBITDA per bed remains lower compared to peers, attributed to a significant presence in non-metro areas with lower ARPOB.
- The company faces challenges in nursing and technical talent retention, although mitigated by strategic initiatives.
- The insurance penetration in Tier 2 and Tier 3 cities remains lower, impacting the overall payer mix and revenue potential.
- The company’s net debt to EBITDA ratio may slightly increase in FY25 due to significant CapEx requirements, although it is expected to decrease thereafter.
Good morning, everyone, I welcome you to Aster DM Healthcare earnings conference call. For the fourth quarter of FY24. The company declared the Q4 and full year financial results for 5/23/24. With this, we have the senior management of Aster DM Healthcare, namely Miss. Alisha Moopen, Deputy Managing Director; Mr. TJ Wilson, Non-Executive Director; Dr Nitish Shetty, Chief Executive Officer India, Mr. Amitabh Johri, Chief Financial Officer GCC; Mr. Sunil Kuma, Chief Financial Officer India; and Mr. Hitesh Dhaddha, Chief of Investor Relations and M&A.
I would like to inform everyone about how we will conduct this call. (Event Instructions) Certain forward-looking statements may be discussed in this meeting and such statements are subject to certain risks and uncertainties like government actions, local political or economic developments, technological risks and many other factors that could cause actual results to differ materially.
Aster DM Healthcare Limited will not be in any way responsible for any action taken based on such statements and undertakes no
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
